Reliv' International, Inc. (RELV) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Reliv' International, Inc. (RELV) trades at $1.83 with AI Score 41/100 (Grade C). Reliv' International, Inc. develops and markets nutritional supplements through a direct selling system. Market cap: $3.20M, Sector: Consumer defensive.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for RELV: RELV does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RELV against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RELV: 1/3 scored disciplines lean bearish. Dominant signal: Ken Griffin bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Reliv' International, Inc. (RELV) Consumer Business Overview
Reliv' International, Inc. operates in the consumer defensive sector, marketing nutritional supplements through a direct selling model across the United States and internationally. Facing a competitive landscape in packaged foods, Reliv focuses on basic nutrition, wellness, weight management, and sports nutrition products, with a current market capitalization of $3.20M.
What Is the Investment Thesis for RELV?
Reliv' International, Inc. presents a unique investment profile within the consumer defensive sector, characterized by its direct selling business model and focus on nutritional supplements. With a market capitalization of $3.20M and a negative P/E ratio of -1.63, the company's financial performance warrants careful consideration. A gross margin of 44.1% indicates a degree of pricing power, while a negative profit margin of -8.4% highlights potential operational inefficiencies or market challenges. Key growth catalysts include expanding its distributor network and introducing innovative product formulations. Potential risks include the inherent challenges of direct selling, regulatory scrutiny of nutritional supplements, and competition from larger, more established players in the packaged foods industry. Investors should closely monitor the company's ability to improve profitability and sustain revenue growth in a dynamic market environment.
Based on FMP financials and quantitative analysis
RELV Key Highlights
Market Cap of $3.20M reflects the company's small size and potential for growth or volatility.
- Gross Margin of 44.1% indicates the company's ability to manage production costs and maintain pricing power in the nutritional supplement market.
- Profit Margin of -8.4% suggests challenges in achieving profitability, requiring attention to operational efficiency and cost management.
- Beta of 0.24 indicates lower volatility compared to the overall market, potentially appealing to risk-averse investors.
- Direct selling model provides a unique distribution channel but also presents challenges in managing and motivating a network of independent distributors.
Who Are RELV's Competitors?
RELV is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AIXN AiXin Life International, Inc. | $0.26 | +0.00% | $6.50M | 39 |
| CEUMF Century Global Commodities Corporation | $0.10 | +0.00% | $12.3M | 49 |
| CLGOF CleanGo Innovations Inc. | $0.79 | +23.40% | $6.32M | 44 |
| BRCNF Burcon NutraScience Corporation | $1.35 | -2.88% | $17.1M | 59 |
| JVA Coffee Holding Co., Inc. | $3.52 | +0.57% | $20.1M | 74 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $2.02 | +0.00% | $35.8M | 64 |
| BUBSF Bubs Australia Limited | $0.08 | +0.00% | $69.2M | 53 |
| LFVN LifeVantage Corporation | $6.58 | +1.31% | $83.1M | 77 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RELV's Key Strengths?
Established direct selling network.
- Proprietary product formulations.
- Brand recognition in select international markets.
- Loyal customer base.
What Are RELV's Weaknesses?
Negative profit margin.
- Limited market capitalization.
- Dependence on distributor network.
- High competition in the nutritional supplement market.
What Could Drive RELV Stock Higher?
Potential expansion into new international markets, driving revenue growth.
- Continued product innovation and development to meet evolving consumer preferences.
- Strengthening of the direct selling network through distributor training and incentives.
- Potential strategic partnerships to expand market reach and brand awareness.
What Are the Key Risks for RELV?
Financial-distress signal — its Altman Z-Score of 0.84 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-19.0%) — the business is not currently generating profit on shareholder capital.
- Regulatory changes affecting the nutritional supplement industry.
- Competition from larger, more established players in the packaged foods market.
- Economic downturns impacting consumer spending on discretionary items.
- Challenges in managing and motivating a network of independent distributors.
- Fluctuations in raw material costs affecting gross margins.
What Are the Growth Opportunities for RELV?
- Expansion into New Geographic Markets: Reliv can pursue growth by expanding its direct selling network into new geographic markets, particularly in Asia and South America, where there is increasing demand for nutritional supplements. Tailoring product offerings to local preferences and regulatory requirements will be crucial for success. This expansion could tap into a market estimated at $150 billion by 2028, offering significant revenue potential.
- Product Innovation and Development: Investing in research and development to create innovative and scientifically-backed nutritional supplements can drive growth. Focusing on emerging trends such as personalized nutrition and plant-based supplements can attract new customers and retain existing ones.
- Enhancing Online Presence and E-commerce Capabilities: Strengthening its online presence and e-commerce capabilities can enable Reliv to reach a broader customer base and improve the efficiency of its direct selling model. Investing in digital marketing, social media engagement, and a user-friendly online platform can drive online sales and brand awareness. The global e-commerce market is expected to reach $6.5 trillion in 2023, highlighting the importance of a strong online presence.
- Strategic Partnerships and Collaborations: Forming strategic partnerships with complementary businesses, such as fitness centers, wellness clinics, and healthcare providers, can expand Reliv's reach and credibility. Collaborating with influencers and health experts can also drive brand awareness and product adoption. Strategic partnerships can provide access to new customer segments and enhance the company's market position.
- Focus on Customer Retention and Loyalty Programs: Implementing customer retention and loyalty programs can help Reliv maintain its existing customer base and drive repeat purchases. Offering exclusive discounts, personalized recommendations, and engaging content can foster customer loyalty and advocacy. Customer retention is crucial for long-term growth, as acquiring new customers is often more expensive than retaining existing ones.
What Are RELV's Competitive Advantages?
- Established direct selling network.
- Proprietary product formulations.
- Brand recognition in select markets.
- Loyal customer base.
What Does RELV Do?
Reliv' International, Inc., founded in 1988 and headquartered in Chesterfield, Missouri, develops, manufactures, and markets nutritional supplements. The company operates within the consumer defensive sector, specifically targeting the packaged foods industry. Reliv's business model centers on a direct selling system, leveraging independent distributors to reach consumers across the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv's product portfolio includes basic nutritional supplements designed to provide comprehensive daily nutrition. Key products include Reliv Classic, Reliv Now, Innergize!, and FibRestore, along with LunaRich X capsules. These products cater to various consumer needs, including general wellness, weight management, and sports nutrition. The company's reliance on a direct selling model differentiates it from traditional retail-focused competitors, presenting both opportunities and challenges in market penetration and brand building. Reliv's financial performance reflects the dynamics of the nutritional supplement market, with a focus on maintaining gross margins and managing operational costs within a competitive environment.
What Products and Services Does RELV Offer?
- Develop and market nutritional supplements.
- Offer products for basic nutrition, wellness, weight management, and sports nutrition.
- Utilize a direct selling system of independent distributors.
- Operate in the United States, Australia, Austria, Canada, and other international markets.
- Offer Reliv Classic, Reliv Now, Innergize!, and FibRestore products.
- Provide LunaRich X capsules for specific wellness needs.
How Does RELV Make Money?
- Direct selling through independent distributors.
- Revenue generation through product sales to distributors and end consumers.
- Focus on recurring revenue through subscription-based programs.
- International expansion to increase market reach.
What Industry Does RELV Operate In?
Reliv' International, Inc. operates within the competitive packaged foods industry, specifically focusing on nutritional supplements. The global nutritional supplements market is characterized by increasing consumer awareness of health and wellness, driving demand for products that support basic nutrition, weight management, and specific wellness needs. The industry is also subject to evolving regulatory standards and intense competition from both established players and emerging brands. Reliv's direct selling model differentiates it from competitors relying on traditional retail channels, but also requires effective management of its distributor network. The company's success depends on its ability to innovate product offerings, maintain quality standards, and adapt to changing consumer preferences in a dynamic market environment.
Who Are RELV's Key Customers?
- Individuals seeking basic nutritional supplements.
- Customers interested in weight management solutions.
- Athletes and fitness enthusiasts.
- Consumers looking for specific wellness products.
Key Financial Metrics
Return on equity for Reliv' International, Inc. stands at -19.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -11.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -33.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.26 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -55.3%, the inverse of the P/E and a quick read on earnings relative to price.
Reliv' International, Inc. (RELV) Valuation Context
Valued at $3.20M, RELV is classified as a micro-cap stock. Relative to its peer group, RELV's quantitative score of 41/100 is below the peer average of 53/100.
Company Profile
Reliv' International, Inc. operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Chesterfield, US. The company is led by CEO Ryan A. Montgomery. RELV has traded publicly since 2016.
Financial Health
Reliv' International, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.84 places it in the distress zone, a signal of elevated financial risk.
RELV Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Reliv's direct selling model could see renewed interest as people seek alternative income streams amidst economic uncertainty.
- Positive buzz in social trading communities suggests growing awareness of Reliv's product line and potential market reach.
- Recent insider buying activity might signal confidence in the company's future performance and long-term value.
- The company's focus on nutritional supplements aligns with increasing consumer interest in health and wellness.
Bear Case
- Direct selling companies face challenges in maintaining consistent sales growth and attracting new distributors.
- Negative sentiment stemming from past controversies or marketing practices could hinder Reliv's brand reputation.
- Increased competition in the nutritional supplement market may make it difficult for Reliv to maintain market share.
- Shifting consumer preferences towards online retail could negatively impact Reliv's traditional distribution model.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
RELV Latest News
No recent news available for RELV.
RELV Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RELV.
Price Targets
Wall Street price target analysis for RELV.
RELV MoonshotScore
What does this score mean?
The MoonshotScore rates RELV 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Ryan A. Montgomery
CEO
Ryan A. Montgomery serves as the CEO of Reliv' International, Inc. His background includes experience in managing and leading teams within the direct selling industry. Montgomery's expertise lies in strategic planning, operational efficiency, and market expansion. He is responsible for overseeing the company's overall performance, driving growth initiatives, and ensuring the effective execution of its business strategy. His leadership is crucial in navigating the competitive landscape of the nutritional supplement market and maintaining Reliv's position.
Track Record: Under Ryan A. Montgomery's leadership, Reliv' International, Inc. has focused on expanding its international presence and enhancing its product offerings. Key achievements include streamlining operational processes to improve efficiency and implementing marketing strategies to drive brand awareness. Montgomery has also emphasized strengthening relationships with the company's network of independent distributors to boost sales and customer retention. His strategic decisions aim to position Reliv for long-term growth and profitability in the dynamic nutritional supplement market.
RELV OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Reliv' International, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may be subject to greater price volatility. Investing in OTC Other stocks carries significant risks due to the lack of regulatory oversight and potential for fraud or manipulation. Investors should exercise extreme caution and conduct thorough due diligence before considering an investment in RELV.
- OTC Tier: OTC Other
- Limited regulatory oversight and disclosure requirements.
- Potential for fraud or manipulation.
- Illiquidity and price volatility.
- Higher risk of delisting or bankruptcy.
- Limited access to company information.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's liquidity and trading volume.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before making any investment decisions.
- Company has been in business since 1988.
- Operates in multiple international markets.
- Offers a range of nutritional supplement products.
- Maintains a direct selling network of independent distributors.
Reliv' International, Inc. Consumer Defensive Stock: Key Questions Answered
What does the AI Score mean for RELV?
RELV holds an AI Score of 41/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Reliv' International, Inc. develops and markets nutritional supplements through a direct selling system. The company offers products addressing basic nutrition, wellness, weight management, …
What does Reliv' International, Inc. do?
Reliv' International, Inc. develops and markets a range of nutritional supplements through a direct selling model. The company's products cater to various consumer needs, including basic nutrition, weight management, and sports nutrition. Reliv operates in multiple international markets, leveraging a network of independent distributors to reach customers.
What do analysts say about RELV stock?
As of 2026-03-16, formal analyst coverage of RELV is limited, likely due to its small market capitalization and OTC listing. Given the lack of analyst ratings, investors should conduct their own thorough due diligence. Key valuation metrics to consider include the company's negative P/E ratio of -1.63 and a gross margin of 44.1%.
What are the main risks for RELV?
Reliv' International, Inc. faces several risks inherent to its business model and industry. These include regulatory scrutiny of nutritional supplements, competition from larger and more established players in the packaged foods market, and economic downturns affecting consumer spending on discretionary items. The company's reliance on a direct selling network also presents challenges in managing and motivating independent distributors.
What are the key factors to evaluate for RELV?
Reliv' International, Inc. (RELV) holds an AI score of 41/100 (low). presents a unique investment profile within the consumer defensive sector, characterized by its direct selling business model and focus on nutritional supplements. Not financial advice.
How frequently does RELV data refresh on this page?
RELV's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven RELV's recent stock price performance?
Reliv' International, Inc. (RELV) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established direct selling network. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RELV overvalued or undervalued right now?
Reliv' International, Inc. (RELV) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research RELV before investing?
Before investing in Reliv' International, Inc. (RELV), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC analysis is based on general characteristics of the OTC Other tier.
- AI insight is pending and not included in this analysis.